HOME >> MEDICINE >> NEWS
OTC statins: A bad decision for public health

This week's editorial raises concerns over the recent decision by the UK government to make the cholesterol-lowering drug simvastatin available over the counter (OTC) from July this year for people at moderate risk of cardiovascular disease.

The editorial comments: 'There are no trials of OTC statins for primary prevention of heart disease. There are no data on compliance with OTC statins, which for products that need to be taken daily longterm is a concern. Will those who buy simvastatin also stop smoking, lose weight, and do more exercise, or will they substitute drug use for lifestyle modification? Will pharmacists have the time to determine the individual's risk of coronary heart disease before selling the drug and also to give lifestyle advice? All these are unknowns, which is unfortunate for the UK public, who will be the guineapigs in this large-scale OTC experiment. Americans have escaped this role, with two applications for OTC statins (pravastatin 10 mg and lovastatin 10 mg) being rejected in 2000 because of insufficient evidence that either drug could be used safely and effectively in an OTC setting'.

Financial reasons are suggested as the driver behind the decision: 'In the absence of evidence of the overall mortality benefits of OTC simvastatin, it is difficult to avoid concluding that the motive behind the Government's decision is saving money. Statins are currently prescribed to about 1.8 million people in the UK, costing the NHS 700 million a year. With the NHS bill for statins predicted to be more than 2 billion a year by 2010, transferring costs to patients might seem timely. But privatising the prevention of heart disease will increase inequalities, with many unable to afford the likely 10-15 per month longterm. For the manufacturer, of course, the motive is clear. With simvastatin now off patent, creation of a new market (perhaps 8 million more people in the UK) will please shareholders'.

The editorial concludes: 'What i
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
20-May-2004


Page: 1 2

Related medicine news :

1. Teaching a less obvious medical skill -- Ethical decision-making
2. Balancing care decisions for gravely ill patients
3. How the stories of ordinary people could give them more say over planning decisions
4. Web-based tool to help clinicians make schizophrenia treatment decisions
5. Fair decisions more important when hospitals face crisis like SARS
6. Testosterone patch will test FDAs decision making
7. Aiding decision making for Baby Charlotte and Baby Luke
8. Scientists detect two decision-making pathways in human brain
9. Concerns about fertility affect treatment decisions in one-third of young breast cancer patients
10. Women pleased with preventative mastectomy decision
11. Exercise sharpens focus, decision-making among aging adults

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/1/2020)... ... September 01, 2020 , ... KitoTech Medical, a ... note financing, which will be used to accelerate the commercialization of its microMend® ... the company will continue to expand its customer base of healthcare systems as ...
(Date:8/31/2020)... ... August 31, 2020 , ... Cardiothoracic surgeons ... biomedical engineers from Carnegie Mellon University (CMU) to develop a new heart monitoring ... undergone open heart surgery. , The AGH/CMU team was recently awarded a “Trailblazer” ...
(Date:8/31/2020)... ... 2020 , ... Want to get moving, break up your routine, and make ... thrilled to launch its fourth annual STEPtember campaign in the United States to raise ... wherever they are at this moment — encouraging people to move in the ways ...
(Date:8/31/2020)... (PRWEB) , ... August 31, 2020 , ... The pandemic and topsy-turvy economic outlook continues ... our budgets and look for ways to trim the fat from our monthly expenses and ... finances, but it’s also important that you have a financial safety net in place in ...
(Date:8/31/2020)... ... August 31, 2020 , ... ... outcomes for patients with advanced heart failure, today announced that the company has ... amount of $555,358 from the National Heart, Lung, and Blood Institute of the ...
Breaking Medicine News(10 mins):
(Date:8/27/2020)... AUSTIN, Texas (PRWEB) , ... August 27, 2020 , ... ... Central Texas – is pleased to announce Dr. David Szalay, DDS, MD, has joined ... to treat patients in the new Pflugerville office, which is scheduled to open this ...
(Date:8/27/2020)... ... August 27, 2020 , ... Bridge To A Cure Foundation announces the ... adult and pediatric neuro-oncologist who serves on the Board of Directors at The Preston ... University Medical School. , Internationally recognized, Dr. Friedman is a widely published author of ...
(Date:8/26/2020)... CHARLES, Mo. (PRWEB) , ... ... ... Services, a member of Eurofins BioPharma Services, Laboratory Testing division, expands its ... the existing suite of Flow Cytometry platforms available. With industry-leading biomarker solutions, ...
Breaking Medicine Technology:
Cached News: